Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts

Stabellini G, Balducci C, Lilli C, Marinucci L, Becchetti E, Carinci F, Calastrini C, Dolci C, Lumare E, Locci P.
Toremifene decreases type I, type II and increases type III receptors in desmoid and fibroma and inhibits TGFbeta1 binding in desmoid fibroblasts.
Biomed Pharmacother. 2007; [Epub ahead of print].
http://www.ncbi.nlm.nih.gov/pubmed/181553952